Nuzenio

Enrollment In Gene

Enrollment In Gene news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 7 publisher sources 100/100 entity strength

Latest news

EyeWorld Weekly, August 7, 2026 - EyeWorldEyeWorld · Fri, 07 Aug 2026 16:04:01 GMT Opus Genetics Completes Phase 3 Enrollment for AAV Gene Therapy OPGx-LCA5 - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:39:16 GMT Opus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease - Eyewire+Eyewire+ · Tue, 04 Aug 2026 13:06:40 GMT Opus Genetics Completes Enrollment in OPGx-LCA5 Phase 3 Trial - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 07:38:27 GMT Opus Genetics Completes Enrollment in Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMT Opus Genetics expects data in 2027 from one-time gene therapy trial - Stock TitanStock Titan · Mon, 03 Aug 2026 11:00:00 GMT Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 11:00:00 GMT Your GBA1 Enrollment Plan Is Built for European Sites — And That’s a Problem - The Clinical Trial VanguardThe Clinical Trial Vanguard · Mon, 03 Aug 2026 07:43:09 GMT

Timeline

Fri, 07 Aug 2026 16:04:01 GMTEyeWorld Weekly, August 7, 2026 - EyeWorld

Wed, 05 Aug 2026 19:39:16 GMTOpus Genetics Completes Phase 3 Enrollment for AAV Gene Therapy OPGx-LCA5 - BioPharm International

Tue, 04 Aug 2026 13:06:40 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease - Eyewire+

Tue, 04 Aug 2026 07:38:27 GMTOpus Genetics Completes Enrollment in OPGx-LCA5 Phase 3 Trial - The Clinical Trial Vanguard

Mon, 03 Aug 2026 11:15:00 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease - Quiver Quantitative

Mon, 03 Aug 2026 11:00:00 GMTOpus Genetics expects data in 2027 from one-time gene therapy trial - Stock Titan

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

OPGx8 live mentions Phase7 live mentions Enrollment7 live mentions Trial7 live mentions Opus Genetics Completes6 live mentions The Clinical Trial4 live mentions Associated Inherited Retinal4 live mentions Eyewire3 live mentions August2 live mentions AAV Gene Therapy2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Enrollment In Gene.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.